<DOC>
	<DOCNO>NCT00709371</DOCNO>
	<brief_summary>The purpose study determine combination zonisamide SR bupropion SR effective either drug give alone placebo treatment obesity .</brief_summary>
	<brief_title>Zonisamide SR Plus Bupropion SR Combination Therapy Subjects With Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Female male subject , 18 65 year age Have body mass index ( BMI ) ≥ 30 kg/m2 ≤ 45 kg/m2 subject uncomplicated obesity , BMI ≥ 27 kg/m2 ≤ 45 kg/m2 subject obesity dyslipidemia and/or control hypertension Nonsmoker use tobacco nicotine product least 6 month prior screen Normotensive ( systolic ≤140 mm Hg ; diastolic ≤90 mm Hg ) . Antihypertensive medication allow exception adrenergic blocker clonidine . Medical regimen must stable least 6 week prior randomization Triglycerides &lt; 400 mg/dL . Medications treatment dyslipidemia allow exception cholestyramine cholestypol long medical regimen stable least 6 week prior randomization No clinically significant laboratory abnormality Negative urine drug screen Negative serum pregnancy test woman childbearing potential Women childbearing potential must nonlactating , agree use acceptable contraception throughout study period 30 day discontinuation study drug Able comply require study procedure schedule Able speak read English Willing able give write informed consent Obesity know endocrine genetic origin ( e.g. , untreated hypothyroidism , Cushing 's syndrome , polycystic ovary syndrome ) Serious medical condition History malignancy within previous 5 year , exception nonmelanoma skin cancer surgically cure cervical cancer . History suicide attempt serious psychiatric illness History Major Depressive Disorder within past 2 year In need medication treatment psychiatric disorder ( exception shortterm insomnia ) within previous 6 month prior randomization Type I Type II diabetes History alcohol drug abuse dependence determine Investigator within 1 year prior randomization History surgical device ( e.g . gastric banding ) intervention obesity History seizures predisposition seizure History hypersensitivity sulfonamide ( `` sulfa '' ) , bupropion , zonisamide History treatment bupropion SR ( Wellbutrin , Zyban ) zonisamide ( Zonegran ) within previous 12 month History nephrolithiasis ( renal calculus ) Loss gain 4.0 kg within 3 month prior randomization Women child bear potential adhere medically acceptable form contraception Pregnant breastfeed woman plan become pregnant study period within 30 day discontinue study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>obesity</keyword>
	<keyword>zonisamide</keyword>
	<keyword>bupropion</keyword>
</DOC>